KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Amgen (AMGN) EBIAT (2016 - 2025)

Amgen (AMGN) has 17 years of EBIAT data on record, last reported at $1.3 billion in Q4 2025.

  • For Q4 2025, EBIAT rose 112.6% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $7.7 billion, up 88.53%, while the annual FY2025 figure was $7.7 billion, 88.53% up from the prior year.
  • EBIAT reached $1.3 billion in Q4 2025 per AMGN's latest filing, down from $3.2 billion in the prior quarter.
  • Across five years, EBIAT topped out at $3.2 billion in Q3 2025 and bottomed at -$113.0 million in Q1 2024.
  • Average EBIAT over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2022.
  • Peak YoY movement for EBIAT: plummeted 103.98% in 2024, then surged 1630.97% in 2025.
  • A 5-year view of EBIAT shows it stood at $1.9 billion in 2021, then decreased by 14.9% to $1.6 billion in 2022, then tumbled by 52.54% to $767.0 million in 2023, then dropped by 18.25% to $627.0 million in 2024, then soared by 112.6% to $1.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were $1.3 billion in Q4 2025, $3.2 billion in Q3 2025, and $1.4 billion in Q2 2025.